Skip to main navigation
Skip to search
Skip to main content
Northwestern Scholars Home
Help & FAQ
Home
Experts
Organizations
Research Output
Grants
Core Facilities
Search by expertise, name or affiliation
Bosentan for the treatment of systemic sclerosis-associated pulmonary arterial hypertension, pulmonary fibrosis and digital ulcers
Manu Jain
*
, John Varga
*
Corresponding author for this work
Medicine, Pulmonary Division
Dermatology
Research output
:
Contribution to journal
›
Review article
›
peer-review
27
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Bosentan for the treatment of systemic sclerosis-associated pulmonary arterial hypertension, pulmonary fibrosis and digital ulcers'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine & Life Sciences
Bosentan
100%
Pulmonary Arterial Hypertension
82%
Pulmonary Fibrosis
81%
Systemic Scleroderma
80%
Ulcer
63%
Endothelin-1
25%
Blood Vessels
20%
Endothelin A Receptors
15%
Therapeutics
11%
Autoimmune Diseases
10%
Fibrosis
8%
Morbidity
6%
Mortality
5%